Mycobacterium paratuberculosis as a cause of Crohn's disease

Adrienne L McNees1, Diane Markesich2, Najah R Zayyani3

  • 1a 1 Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.

Insights

Mycobacterium avium paratuberculosis (MAP) may cause Crohn's disease, a chronic inflammatory bowel disease. Further research is needed to confirm if MAP is the definitive cause of Crohn's disease in humans.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Immunology

Background:

  • Crohn's disease is a chronic inflammatory bowel disease affecting 1.4 million North Americans, with unknown etiology.
  • Johne's disease, a ruminant enteritis caused by Mycobacterium avium paratuberculosis (MAP), shares similarities with Crohn's disease.
  • MAP is a widespread pathogen in cattle, posing a risk of human exposure through contaminated food and water due to environmental persistence and resistance to disinfection.

Purpose of the Study:

  • To evaluate the current evidence linking Mycobacterium avium paratuberculosis (MAP) to Crohn's disease.
  • To discuss the data required to establish or refute MAP as a causative agent of Crohn's disease.

Main Methods:

  • Review of existing scientific literature on MAP and Crohn's disease.
  • Analysis of MAP culture data from Crohn's disease patients and healthy individuals.

Main Results:

  • MAP has been cultured from a high percentage of Crohn's disease patients' peripheral mononuclear cells (50-100%), with lower detection rates in healthy individuals.
  • The presence of MAP in Crohn's disease patients indicates an association, but does not confirm causation.

Conclusions:

  • While a strong association exists, current data is insufficient to definitively prove or disprove Mycobacterium avium paratuberculosis (MAP) as the cause of Crohn's disease.
  • Further research is necessary to elucidate the etiological role of MAP in Crohn's disease.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
758
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
676
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.1K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
915